ADVERTISEMENT



Google       

Home -> Law Blog Directory -> Intellectual Property Law Blogs -> Two-Seventy-One Patent Blog

OR PHONE (866) 635-1838 for Bankruptcy Help, (866) 635-6190 for Divorce,
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense

Find a Local Lawyer

Bankruptcy (866) 635-1838
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402

Bookmark

Intellectual Property Law

: Two-Seventy-One Patent Blog

Consumer Groups File CAFC Amicus Brief in Support of USPTO Rule Changes

By Peter Zura

ADVERTISEMENTS
A coalition of consumer advocacy and public interest groups recently filed an amicus brief at the CAFC, arguing that the PTO's "continuation rule changes" would curtail abusive behavior by patent applicants and improve patent quality.

The brief continues the same themes raised in earlier amicus briefs at the district court, that endless continuations harm the public good and hinder innovation. While being light on substantive legal analysis, the brief manages to poke some thumbs into the eyes of those seeking to block the continuation rules.

These excuses [for opposing the rules] lack any technological or economic merit, because any claims desired and deserved by a patent applicant can and should be included in the original application, an amendment to it, or any of the continuation applications allowed under the Final Rules as a matter of right without justification. The failure to do so would be caused by the patent applicant's own delay in recognizing what it is they want to claim, and not by the USPTO or its Final Rules.

* * *

[T]here have been several patents that were used to preclude competition in markets worth billions of dollars that were later proven to be undeserved.
One industry where this phenomenon repeatedly occurs is the pharmaceutical
industry . . . consumers of pharmaceuticals are especially prone to the negative effects of poor patent quality, as markets with monopolies maintained by undeserved patents force consumers to spend much more on drugs than they would if the market was subject to competition unrestrained by invalid patents.

* * *

[A]rguments regarding the public interest made by patent holders and patent attorneys should be carefully scrutinized, because these groups are actually, in fact, the special interests that benefit from the patent system and what benefits them personally may not actually benefit the public interest.

The groups joining in filing the Public Interest Amici brief are: The Public Patent Foundation (?PUBPAT?), AARP, Computer & Communications Industry Association (?CCIA?), Consumer Watchdog (Formerly the Foundation for Taxpayer and Consumer Rights), Essential Action, Initiative for Medicines, Access & Knowledge (?I-MAK?), Prescription Access Litigation (?PAL?), Public Knowledge (?PK?), Research on Innovation (?ROI?), and Software Freedom Law Center (?SFLC?).

Download the brief in its entirety here, courtesy of PubPat.

Full post as published by Two-Seventy-One Patent Blog on July 29, 2008 (boomark / email).

Bloggers, promote your law blog by nominating your blog for inclusion in USLaw.com's Law Blog Directory and RSS Reader. Benefits described.
Related Law Articles

Lawsuits and Settlements

Related Searches

























































































































US Law
#1 Online Legal Resource













Your Blog Subscriptions
Subscribe to blogs

10,000+ Law Job Listings
Lawyer . Police . Paralegal . Etc
Earn a law-related degree
Are you the author of this blog? Adding USLaw.com to your Blogroll increases relevance. You qualify to display a USLaw Network badge.
Suggest changes to this blog's description or nominate another for inclusion. Register for updates.


Practice Area
Zip Code:

Contact a Lawyer Now!






0.0024 secs (from cache 10/31/26 22:58:41)